Jason Reddish JD
Partner, Feldesman Tucker Leifer Fidell LLP
Appearances
DateMarch 10, 2023This session will provide a general update on the 340B Drug Pricing Program that includes the topics of litigation status, manufacturer restrictions, and any anticipated regulatory challenges related to the program…Speakers
Elizabeth Linderbaum, MPPDeputy Director, Regulatory Affairs, NACHCJason Reddish, JDPartner, Feldesman Tucker Leifer Fidell LLPPeggy Tighe, JDPrincipal, Powers Pyles Sutter & Verville PC
DateMarch 10, 2023Protecting 340B savings starts at the contracting phase when working with PBMs, contract pharmacies, third-party administrators, and managed care organizations…Speakers
Felicity Homsted, PharmD, MBAChief Executive Officer, FQHC 340B ComplianceJason Reddish, JDPartner, Feldesman Tucker Leifer Fidell LLPLogan Yoho, PharmD, RPh, BCACPDirector of Pharmacy, Hopewell Health Centers, Inc.Moderator
Jangus Whitner, PharmD, MHA, BCACP, 340B ACEManager, 340B Policy and Compliance, Apexus
